Towards Safer Drug Treatment and Enhanced Patient Empowerment | The SafePolyMed Project

Age, biological sex, genetic constitution, and current or chronic disease status are among the pivotal factors influencing how drugs interact with each other and our bodies. A "one-size-fits-all" strategy in drug therapy is therefore often inadequate, especially when dealing with the simultaneous prescription of multiple medications, which increases the risk of serious side effects.
Changing the state of the art and working towards the implementation of personalised drug therapy is essential to reduce hospitalisations and deaths attributed to adverse drug reactions. The EU-funded SafePolyMed project is on such an ambitious mission, with international partners working to provide physicians, pharmacists, and patients with innovative tools to define, assess, and manage drug interactions on an individual level. The project is also designing a new approach to involve and empower patients in managing their healthcare proactively.
For more information on the project, please visit:
safepolymed.eu/
#PatientSafety #DrugSafety #AdverseDrugReactions
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.